A review on newly approved PARP inhibitors: Talazoparib and Olaparib

A review on newly approved PARP inhibitors: Talazoparib and Olaparib

This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Библиографические подробности
Главный автор:	Karim, Azrin
Другие авторы:	Islam, Farzana
Формат:	Project report
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	PARP inhibitors Olaparib Talazoparib DNA damage repair DDR signaling pathway Homologous recombination repair Prostate cancer Ovarian cancer Metastatic breast cancer BRCA mutations Cancer > Treatment > Genetic aspects. DNA repair. NAD-ADP-ribosyltransferase > Inhibitors > Therapeutic use. Antineoplastic agents.
Online-ссылка:	http://hdl.handle.net/10361/24372

Схожие документы

A review on potential of PARP inhibitors in the treatment of prostate cancer
по: Islam, Saidul
Опубликовано: (2022)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
по: Ahmed, Nafisa
Опубликовано: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
по: Meem, Manila
Опубликовано: (2023)

Mutation in DNA polymerase γ: mitochondrial disorders
по: Hossain, Sadman Sanjid
Опубликовано: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
по: Alam, Tahera
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

Statistics and informatics in molecular cancer research

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
по: Parvin, Salma, и др.
Опубликовано: (2016)

Association of MTHFR rs1801133, PEMT rs4244593, CHKA rs7928739, VNTRs IL-1RN intron 2 and NOS3 intron 4 polymorphisms with unexplained intrauterine fetal death in Bangladeshi population
по: Mahasin, Deera, и др.
Опубликовано: (2024)

Repairing & maintaining yard equipment & power tools /
по: Schultz, Mort J.
Опубликовано: (1994)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
по: Mirza, Maisa Tasnim
Опубликовано: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

Cancer risk factors: a critical review
по: Tabassum, Tahsina
Опубликовано: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
по: Nawar, Anika
Опубликовано: (2019)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
по: Mondal, Shawon
Опубликовано: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
по: Khan, Muidul Hasan
Опубликовано: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
по: Abir, Shifaty Nur
Опубликовано: (2024)

Targeting BRAFV600E in the treatment of CRC
по: Roja, Mashwiyat Samrin
Опубликовано: (2024)

Role of statins as antagonists of SPARC in gastric cancer
по: Shahmat, Rad
Опубликовано: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
по: Pial, Sazia Afrin
Опубликовано: (2018)

A review on the role of histone deacetylase SIRT6 in high-grade serous ovarian Cancer
по: Rahman, Tazin
Опубликовано: (2022)

Epigenetic therapy in cancer
по: Abid, Md. Shadman Ridwan
Опубликовано: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
по: Khondokar, Faiza
Опубликовано: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
по: Rahman, Sanjida
Опубликовано: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
по: Emon, Kamrul Hasan
Опубликовано: (2022)

Biosimilar in lymphoma treatment
по: Tanisha, Mehrin Haque
Опубликовано: (2021)

Molecules associated with the development of lung cancer
по: Rahman, Adree, и др.
Опубликовано: (2023)

Current perspectives on cancer prevention strategies: implications for Bangladesh
по: Afrin, Sajia
Опубликовано: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
по: Hossain, Safa Binte
Опубликовано: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
по: Islam, Karima
Опубликовано: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
по: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
по: Yasmin, Rizwana
Опубликовано: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
по: Sorno, Rubina Haque
Опубликовано: (2024)

Radar for technicians : installation, maintenance, and repair /
по: Gould, Frederick L.
Опубликовано: (1995)

Breast cancer awareness seminars
по: Anwer Khan Modern Medical College
Опубликовано: (2016)

Protein biomarkers for Lung Cancer: a bioinformatic approach
по: Jeba, Joynob
Опубликовано: (2017)

Current scenario of Cancer in Dhaka City, Bangladesh
по: Natth, Bratakatha
Опубликовано: (2016)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
по: Pecorino, Lauren
Опубликовано: (2012)